Webinar 12 | DCBs in Coronary Bifurcation Lesions-The Return of Balloon PTCA, Dr. Spencer B. King III

Video Transcription

Video Summary

The speaker reflects on the lessons learned from early coronary balloon angioplasty before stents, emphasizing how angioplasty reduced angina but had higher complication and repeat procedure rates than surgery. Key findings from historic trials include that high balloon pressure improves lesion opening, oversized balloons increase dangerous dissections, and that uncomplicated dissections do not predict restenosis. Longer balloon inflation times reduce recoil and improve outcomes—unlike current practice where inflations are brief due to stenting holding vessels open. Experimental data showed stents cause chronic injury and inflammation leading to more arterial proliferation than balloons alone, partially explaining late stent complications. Drug delivery to limit proliferation is crucial, as seen in brachytherapy and modern drug-coated balloons (DCBs). The discussion highlights how many foundational angioplasty principles remain relevant today, especially with DCB use. Concerns about multiple DCB applications or combining DCBs and stents were addressed, with no increase in adverse effects observed so far. The talk underlines a valuable blend of past insights with current innovations in interventional cardiology.

Keywords

coronary balloon angioplasty

stents

angioplasty complications

drug-coated balloons

interventional cardiology